
Diagnoly helps clinicians improve prenatal screening by providing real‑time AI analysis of fetal ultrasound to detect abnormalities and ensure complete exams. It builds Fetoly, a DeepTech B2B SaaS and medical device that uses AI and deep learning models integrated with ultrasound systems to provide on‑device, real‑time feedback during scans. Fetoly analyzes anatomical landmarks, detects over 100 fetal abnormalities, validates exam completeness against ISUOG guidelines, and automates repetitive measurements to increase consistency. The solution runs locally on mobile devices and remains compatible with major ultrasound platforms without requiring cloud services, preserving clinical data control. Diagnoly targets obstetricians and healthcare providers and holds FDA clearance for Fetoly‑Heart and CE marking for fetal heart and brain analysis.

Diagnoly helps clinicians improve prenatal screening by providing real‑time AI analysis of fetal ultrasound to detect abnormalities and ensure complete exams. It builds Fetoly, a DeepTech B2B SaaS and medical device that uses AI and deep learning models integrated with ultrasound systems to provide on‑device, real‑time feedback during scans. Fetoly analyzes anatomical landmarks, detects over 100 fetal abnormalities, validates exam completeness against ISUOG guidelines, and automates repetitive measurements to increase consistency. The solution runs locally on mobile devices and remains compatible with major ultrasound platforms without requiring cloud services, preserving clinical data control. Diagnoly targets obstetricians and healthcare providers and holds FDA clearance for Fetoly‑Heart and CE marking for fetal heart and brain analysis.
Product: Fetoly — on-device, real-time AI for fetal ultrasound (landmarking, QA, anomaly detection)
Regulatory: FDA clearance for Fetoly-Heart and CE marking for fetal heart and brain analysis
Founded: 2020 — Lyon, France
Latest funding: Seed round announced Apr 8, 2025 (€5.5M reported)
| Company |
|---|
Prenatal fetal ultrasound quality assurance and anomaly detection
2020
Medical Equipment Manufacturing
€5.5M
Reported seed round announced Apr 8, 2025; participants include Mutuelles Impact, Newfund and existing investor BAdGE
Profiles list multiple prior funding events and non-equity assistance but details not specified in evidence
“Mutuelles Impact and Newfund participate as lead investors in the Seed round; additional investors reported across rounds include XAnge, Les Business Angels des Grandes Écoles, WorldUpstart, Angelor, MassChallenge Switzerland”
About Diagnoly
Diagnoly is redefining obstetric and maternal-fetal medicine through real-time AI in ultrasound. We are seeking a driven and ambitious Sales Representative for Europe. This role is ideal for motivated, hands-on sales professionals who want to make a real impact in women’s health. You will play a key role in building Diagnoly’s presence in Europe, particularly with large OB and MFM clinics, health systems, and private practices.
Role overview
We are looking for a proactive, hands-on Product Manager with deep understanding of MedTech and medical imaging workflows. You will play a central role in shaping the future of Diagnoly’s AI-powered product — bridging customer needs, engineering, clinical partners, and business strategy. This role is ideal for someone who thrives in a fast-paced startup where ownership, autonomy, and clear communication are key.
KEY RESPONSABILITIES
Product Strategy & Roadmap
Customer & Clinical Interaction
Product Development & Release Management
OEM & Partner Coordination
PROFILE
Nice to have
Why join us ?
If you are interested, do not hesitate to write us on careers@diagnoly.com with your CV.